Tech Company Financing Transactions
ImmunoPhotonics Funding Round
ImmunoPhotonics closed a $2.5 million funding round on 1/22/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/22/2015
Transaction Type
Venture Equity
Amount
$2,487,487
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4340 Duncan Ave. 212
St. Louis, MT 63110
USA
St. Louis, MT 63110
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Developing a novel immunotherapy inCVAX, a minimally invasive vaccine that intends to cause a systemic antitumor response to treat late-stage metastatic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lu Alleruzzo
President
Tomas Hode
Vice President
Joseph Raker
VP - Bus. Development
Troy Jiao
VP - Bus. Development
Theresa Visarius
VP - R & D
Siu Lam
VP - Regulatory Affairs
Diane Beatty
Browse more venture capital transactions:
Prev: 1/22/2015: Intradiem venture capital transaction
Next: 1/22/2015: Keaton Row venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs